Kurs & Likviditet
Beskrivning
Land | Danmark |
---|---|
Lista | First North Denmark |
Sektor | Informationsteknik |
Industri | Programvara |
24.6.2021 13:56:43 CEST | Monsenso | Company Announcement
Company announcement no. 13-2021
Copenhagen, 2021.06.24
Board members, executive management and founders of Monsenso A/S have decided to extend the lock-up period for their shares. In total, the agreement covers more than 1/3 of the company's share capital and votes.
"The board of directors, executive management and founders have no plans to sell shares now", says CEO Thomas Lethenborg. "We all see a significant long-term potential in Monsenso and in the growing digital mental health market, and we will continue to support releasing that potential.”
The lock-up agreement means that the parties have committed to keep their shares in the company until January 14, 2022, after which the number of shares locked-up are reduced by 10 per cent every month until October 15, 2022, when all shares will be released.
Any inquiries regarding this notice should be directed to:
Monsenso
Chairman of the board
Maria Hjorth
Tel. +45 25 55 63 39
E-mail: maria.hjorth@gmail.com
CEO
Thomas Lethenborg
Tlf. +45 21 29 88 27
E-mail: lethenborg@monsenso.com
Certified Adviser
Norden CEF ApS
John Norden
Tlf. +45 20 72 02 00
E-mail: jn@nordencef.dk
About Monsenso
Monsenso is an innovative technology company offering a digital health solution for mental health and behavioral disorders. Our mission is to help provide better mental health to more people at lower costs. Our solution helps optimise the treatment of mental disorders and gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. Based on continuous research and development, our team is committed to developing solutions that fit seamlessly into the lives of individuals, increase their quality of life and improve the efficacy of mental health treatment. To learn more visit www.monsenso.com